Reconciling peptide research specimen custody without confusing location with integrity

A specimen can be present in the expected freezer and still have an incomplete history. It can also have a tidy transfer log while its temperature exposure or processing history makes it unsuitable for a particular analysis. Custody reconciliation addresses the first problem. Scientific and quality review address the second.

The record to reconcile

A useful custody record connects the specimen identifier with collection or creation, container, aliquot relationship, storage position, handler, timestamps, transfers, shipments, receipt checks, and final disposition. The exact fields depend on the protocol, repository procedure, and system design.

NCI biospecimen best practices emphasize documented procedures and quality management across collection, processing, storage, retrieval, and distribution. FDA electronic-record guidance adds expectations around preserving authenticity, integrity, confidentiality, meaning, and associated metadata for covered clinical-investigation records.

Where gaps appear

Reconciliation should occur when a specimen changes hands or state. Common checkpoints include collection-to-processing transfer, aliquoting, freezer moves, courier dispatch, destination receipt, analysis issue and return, and destruction or exhaustion.

At each checkpoint, compare expected and observed identifiers, count, container type, location, seal or package condition where used, and timestamps. Record differences without silently correcting the source. A missing vial, duplicate identifier, undocumented aliquot, or impossible sequence needs an exception record and a named owner.

Administrative coordinators can compare records, request documents, and route discrepancies. They should not decide that an exposure had no effect, that mislabeled specimens are equivalent, or that a sample can be used. Those decisions require qualified study, laboratory, and quality personnel.

Measures that stay honest

Useful operational measures include unreconciled transfers, time from receipt to confirmation, missing custody fields, and exceptions by transfer point. A percentage alone needs a denominator and a defined observation period. Teams should avoid combining protocol deviations, temperature excursions, and simple documentation delays into one "quality" score.

Scope and limitations

This review summarizes general public guidance and best-practice concepts. It does not prescribe a biospecimen system, replace a protocol, or determine regulatory applicability. Requirements vary with specimen type, study design, consent, jurisdiction, sponsor instructions, and intended use.

Custody documentation cannot reconstruct an event that was never recorded. It also cannot establish analyte stability, rule out contamination, or prove clinical provenance without other evidence. A qualified program should connect custody review with deviation, temperature, consent, privacy, and analytical procedures.

Sources

• NCI Best Practices for Biospecimen Resources
• FDA electronic systems and records guidance
• ISBER Best Practices overview